Pharmatek Animal Health Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
About Pharmatek Animal Health
Pharmatek Animal Health Private Limited (PAHPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 September 2016 (Eight years and four months 25 days old ). Its registered office is in Haridwar, Uttarakhand, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Firoz Khan and Mohd Khan serve as directors at the Company.
Company Details
- Location
Haridwar, Uttarakhand, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999UR2016PTC007336
- Company No.
007336
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Sep 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
What products or services does Pharmatek Animal Health Private Limited offer?
Pharmatek Animal Health Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Bird Food, Poultry & Animal Food, Animal Feed Supplement, Animal Medicines & Health Care, Veterinary Injections, Ayurvedic,Herbal Products & Medicine, Pain Balm & Ointments.
Who are the key members and board of directors at Pharmatek Animal Health?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Firoz Khan  | Director | 30-Sep-2016 | Current |
| Mohd Khan | Director | 30-Sep-2016 | Current |
Financial Performance of Pharmatek Animal Health.
Pharmatek Animal Health Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Pharmatek Animal Health?
In 2017, Pharmatek Animal Health had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Samar Infra Private LimitedFiroz Khan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmatek Animal Health?
Unlock and access historical data on people associated with Pharmatek Animal Health, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmatek Animal Health, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmatek Animal Health's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.